Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.
If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices.
What can I do to prevent this in the future?
Another way to prevent getting this page in the future is to use Privacy Pass. You may need to download version 2.0 now from the Chrome Web Store.
If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.
Cloudflare Ray ID: 6650ed3f0babfe48 • Your IP : 220.127.116.11 • Performance & security by Cloudflare
In fact, we’re funding a clinical trial through our Virtual Biotech right now. In a world first clinical trial, Professor Sagnik Bhattacharyya and Dr Latha Velayudhan at Kings College London (KCL) will be testing whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms.
CBD oil is available to buy legally as a food supplement. But it can’t be advertised as beneficial for medicinal purposes as there is not enough evidence currently.
Between January and March 2019, we asked people with Parkinson’s and health professionals to tell us about their experiences with and opinions on using cannabis-based products.
Our policy panel will discuss these findings at their November 2019 meeting and agree what we think as an organisation and our next steps.
We’ve now analysed their answers and produced a short report sharing our key findings.
The use of CBD is legally gray, as marijuana is illegal at the federal level. However, the 2018 U.S. Farm Bill legalized the use of CBD produced via the cultivation of hemp with THC levels below 0.3 percent.
Because CBD is unregulated at the federal level, it can be difficult to determine the amount of THC in certain products. Purchasing CBD products from reputable brands that conduct third-party testing is currently the safest option.
What is CBD?
CBD has shown potential in early studies for reducing dyskinetic activity in people with PD and treating motor symptoms in various neurodegenerative conditions.
According to a 2018 review study published by the journal Frontiers in Pharmacology, “Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects.” Data also suggest that CBD could potentially play a protective role in the treatment of certain movement disorders. Results are promising, but further studies are needed to clarify the efficacy of CBD.
You also can use a medical marijuana card to obtain CBD in some states. Nevertheless, a few states currently forbid the use of CBD. Check to see if CBD is legal in your state here.